Literature DB >> 12381507

Staging of patients with ankylosing spondylitis: a preliminary proposal.

J Braun1, D van der Heijde, M Dougados, P Emery, M A Khan, J Sieper, Sj van der Linden.   

Abstract

Patients with ankylosing spondylitis (AS) are characterised by a wide range of clinical presentations, radiographic profiles, and outcomes, which are not well differentiated by current diagnostic and classification systems for the disorder. Inadequacies in these systems may limit clinicians' ability to manage their patients with AS appropriately and act as an obstacle to reasonable comparison of therapeutic trial results. A standardised staging system for AS is therefore proposed that would provide a more detailed categorisation of patients based on assessment of structural damage, peripheral joint and organ involvement, presence of concomitant diseases, and the severity and extent of disease activity and functional impairment. The proposed system needs to be evaluated closely and amended as needed to assure its usefulness in clinical and research settings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381507      PMCID: PMC1766734          DOI: 10.1136/ard.61.suppl_3.iii19

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

1.  Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year.

Authors:  A Spoorenberg; K de Vlam; D van der Heijde; E de Klerk; M Dougados; H Mielants; H van der Tempel; M Boers; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 2.  Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.

Authors:  D van der Heijde; A Calin; M Dougados; M A Khan; S van der Linden; N Bellamy
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

3.  Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte.

Authors:  K de Vlam; H Mielants; E M Veys
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

Review 4.  Radiologic diagnosis and pathology of the spondyloarthropathies.

Authors:  J Braun; M Bollow; J Sieper
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

5.  The outcome of ankylosing spondylitis: a study of 100 patients.

Authors:  J T Gran; J F Skomsvoll
Journal:  Br J Rheumatol       Date:  1997-07

6.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

7.  Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

Authors:  D van der Heijde; N Bellamy; A Calin; M Dougados; M A Khan; S van der Linden
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

Review 8.  Imaging of sacroiliitis.

Authors:  J Braun; J Sieper; M Bollow
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

9.  Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.

Authors:  J Brandt; M Bollow; J Häberle; M Rudwaleit; U Eggens; A Distler; J Sieper; J Braun
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

10.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12
View more
  16 in total

Review 1.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis.

Authors:  Taciser Kaya; Fazil Gelal; Rezzan Gunaydin
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

3.  Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.

Authors:  Belkıs Nihan Coşkun; Mustafa Ferhat Öksüz; Selime Ermurat; Ayşe Nur Tufan; Nurdan Oruçoğlu; Akif Doğan; Ediz Dalkılıç; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2014-09-01

4.  Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.

Authors:  Martin Rudwaleit; Pascal Claudepierre; Martina Kron; Sonja Kary; Robert Wong; Hartmut Kupper
Journal:  Arthritis Res Ther       Date:  2010-03-15       Impact factor: 5.156

Review 5.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

6.  Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).

Authors:  M Dougados; J Braun; S Szanto; B Combe; M Elbaz; P Geher; G Thabut; V Leblanc; I Logeart
Journal:  Ann Rheum Dis       Date:  2011-02-13       Impact factor: 19.103

7.  Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

Authors:  M Rudwaleit; E Rødevand; P Holck; J Vanhoof; M Kron; S Kary; H Kupper
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

8.  Treatment of ankylosing spondylitis: focus on etanercept.

Authors:  Tracy Frech
Journal:  Biologics       Date:  2007-03

9.  Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis.

Authors:  K Prajzlerová; M Komarc; Š Forejtová; K Pavelka; J Vencovský; L Šenolt; M Filková
Journal:  Physiol Res       Date:  2021-03-08       Impact factor: 1.881

10.  Analysis of PPARGC1B, RUNX3 and TBKBP1 polymorphisms in Chinese Han patients with ankylosing spondylitis: a case-control study.

Authors:  Zijian Lian; Wei Chai; Lewis L Shi; Chao Chen; Jingyi Liu; Yan Wang
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.